drugset / Trial / NCT02390440
Exparel for Pain Control During Care of Rib Fractures
NaSingle-groupOpen-labelTreatment
Summary
This study is looking at a novel therapy of numbing medication injected directly around the fracture site. The purpose of this study is to determine if the study medication, EXPAREL®, is a viable alternative to current therapies for rib fractures.
Timeline
- Start
- 2015-04
- Primary completion
- 2017-01
- Completion
- 2017-01
Outcome
Outcome not reported
Stopped: “Did not obtain an IND.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
Indications
No indication recorded.